Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ANGELA M GARCIA-GRIDER

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1619228632
CMS profile
11222778
Location
HIGH POINT, NC

General Payments · PY2022–2024

$579.96

  • Reported across 23 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$371.81

17 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $371.81 17

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $207.50 14
Acerta Pharma LLC $149.77 2
ABBVIE INC. $14.54 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $99.41 2
PY2023 $108.74 4
PY2024 $371.81 17

Payment records · PY2024 (17)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $14.54 01/04/2024 Food and Beverage Undisputed 01/23/2026 1107149956 CMS
AstraZeneca Pharmaceuticals LP $49.03 06/14/2024 Food and Beverage Undisputed 01/23/2026 1105676185 CMS
AstraZeneca Pharmaceuticals LP $100.74 09/25/2024 Food and Beverage Undisputed 01/23/2026 1104536275 CMS
Novo Nordisk Inc $6.04 01/09/2024 Food and Beverage Undisputed 01/23/2026 1100235954 CMS
Novo Nordisk Inc $6.79 02/07/2024 Food and Beverage Undisputed 01/23/2026 1100533223 CMS
Novo Nordisk Inc $7.17 02/19/2024 Food and Beverage Undisputed 01/23/2026 1100281144 CMS
Novo Nordisk Inc $6.98 03/08/2024 Food and Beverage Undisputed 01/23/2026 1100525409 CMS
Novo Nordisk Inc $5.68 04/15/2024 Food and Beverage Undisputed 01/23/2026 1100368655 CMS
Novo Nordisk Inc $7.05 05/08/2024 Food and Beverage Undisputed 01/23/2026 1100307187 CMS
Novo Nordisk Inc $7.61 05/22/2024 Food and Beverage Undisputed 01/23/2026 1100513211 CMS
Novo Nordisk Inc $5.84 06/11/2024 Food and Beverage Undisputed 01/23/2026 1100573530 CMS
Novo Nordisk Inc $121.85 06/13/2024 Food and Beverage Undisputed 01/23/2026 1100296787 CMS
Novo Nordisk Inc $6.23 09/12/2024 Food and Beverage Undisputed 01/23/2026 1100349296 CMS
Novo Nordisk Inc $6.64 09/17/2024 Food and Beverage Undisputed 01/23/2026 1100250556 CMS
Novo Nordisk Inc $8.27 10/17/2024 Food and Beverage Undisputed 01/23/2026 1100285786 CMS
Novo Nordisk Inc $4.44 10/31/2024 Food and Beverage Undisputed 01/23/2026 1100654779 CMS
Novo Nordisk Inc $6.91 11/20/2024 Food and Beverage Undisputed 01/23/2026 1100358904 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.